Back
Corporate News
Astec LifeSciences reports Rs 84.3 crore income, narrows loss to Rs 18.7 crore
31-Jul-2026, 10:11
Astec LifeSciences Limited announced its financial results for the quarter ended June 30, 2026, reporting consolidated total income of Rs 84.3 crore, compared to Rs 91.6 crore in the same quarter of the previous year. The company posted a consolidated loss after tax of Rs 18.7 crore, down from a loss of Rs 33.0 crore in Q1FY26, and achieved EBITDA breakeven compared to an EBITDA loss of Rs 10.5 crore in the prior year, supported by a favorable product mix and improved margins. According to Chairman Vishal Sharma, revenue from Enterprise Products grew 42% year-on-year to Rs 51.8 crore, while revenue from CDMO Products stood at Rs 31.8 crore.
Astec LifeSciences Limited announced its financial results for the quarter ended June 30, 2026, reporting consolidated total income of Rs 84.3 crore, compared to Rs 91.6 crore in the same quarter of the previous year. The company posted a consolidated loss after tax of Rs 18.7 crore, down from a loss of Rs 33.0 crore in Q1FY26, and achieved EBITDA breakeven compared to an EBITDA loss of Rs 10.5 crore in the prior year, supported by a favorable product mix and improved margins. According to Chairman Vishal Sharma, revenue from Enterprise Products grew 42% year-on-year to Rs 51.8 crore, while revenue from CDMO Products stood at Rs 31.8 crore.